TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) and ADNOC Gas announced today a five-year liquefied natural gas (LNG) supply agreement, under which ADNOC Gas will supply a total of up to 1.6 million ...
Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the ...
Teva to obtain U.S. commercialization rights for two immunology biosimilars: ETICOVO ® upon close and infliximab-abda in Q3 2027; Collaboration combines Samsung Bioepis’ biosim ...
US$220 Million ACG Metals Equity Consideration with Blue Moon to Focus on its U.S. Critical Metals Assets. TORONTO, Nov. 3, 2026 /PRNewswire/ -- Blue Moon Metals Inc. ("Blue Moon" ...
Coca-Cola Europacific Partners (NASDAQ:CCEP) reported stronger-than-expected third-quarter trading, supported by higher beverage volumes and revenue growth across its European and Asia Pacific ...
V2X (NYSE: VVX) delivered a third quarter that looks better against consensus than against the bar investors actually set. Adjusted EPS of $1.64 topped the $1.54 consensus but fell 2.4% short of the ...
(NYSE: KTB) today announced it has completed the sale of the Lee ® business to Authentic Brands Group. "I want to thank the Kontoor team for the tremendous effort that drove the successful completion ...
Del Monte Corporation (NYSE: DMC) today announced that management will participate in Stephens Annual Investment Conference to be held November 17-19, 2026, at The Grand Hyatt in Nashville, Tennessee.
TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) and ADNOC Gas announced today a five-year liquefied natural gas (LNG) supply agreement, under which ADNOC Gas will supply a total of up to 1.6 million ...
Grifols reported a 27.9% increase in third-quarter net profit to €162 million, alongside higher adjusted operating profitability. Adjusted EBITDA reached €538 million, up 9.8% at constant currency, ...
Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system disorders, today ...
Citing people familiar with the discussions, Bloomberg reported that Disney has asked certain managers to identify opportunities to achieve annual cost savings of 20%. The proposed measures come as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results